Kintara Therapeutics, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
KTRA on Nasdaq
Location
9920 Pacific Heights Blvd, Suite 150, San Diego, CA

There are no Buy or Sell transactions made by insiders since 9/17/2023

Kintara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anthony Scott Praill Chief Financial Officer $188K Aug 1, 2022
Saiid Zarrabian Head of Strategic Partnerships, Director $38K Dec 6, 2021
Laura L. Johnson Director Aug 30, 2023
Robert E. Hoffman President, CEO and Interim CFO, Director Aug 30, 2023
Robert Joseph Jr Toth Director Aug 30, 2023
Dennis M. Brown Chief Scientific Officer Aug 30, 2023
Tamara A. Favorito Director Aug 30, 2023
Keith Murphy Director Sep 22, 2021

Recent Insider Transactions by Companies or Individuals for Kintara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.